The Value-Based Care Trap Part 2: The Hidden Costs of Change (and How Not to Get Burned)

People are saying we should fight for value-based care (which means —track outcomes, join networks, prove your value). But almost no one is talking about the bill  that comes with that shift. In Part 2, The Hidden Costs of Change (and How Not to Get Burned), we break down the real price tag: data, culture, politics, and risk you don’t control. Before you play the VBC game, you need to know exactly what you’re putting on the table. 

Blog:

In Part 1, we looked at why VBC is suddenly on everyone’s lips in O&P—and why it’s both a real opportunity and a potential trap. Now let’s get more concrete: what does it actually cost a small practice to “do VBC,” and what mindsets in the system do we need to challenge to make it worth the effort? 

The real cost of change

1. Building a basic outcomes infrastructure

Any serious role in VBC requires some level of outcomes measurement and reporting. For O&P, that usually means: 

• A minimal outcome set: functional measures (AMP/LCI type tools, gait speed or 6MWT), plus falls, ED visits, and rehospitalizations at defined follow-up points. 

• Workflows so clinicians can collect and document those measures consistently. 

• A way to aggregate and summarize data for your top diagnostic groups. 

Avalere explicitly calls out our profession’s challenges here: fragmented services, highly customized devices, and limited visibility into clinician level activity make standardized measurement hard. Getting this even “good enough” takes time, training, and usually some technology investment—almost none of which is reimbursed directly. 

2. Leadership and culture shifts inside the practice

VBC asks your team to think differently: 

• Clinicians must see themselves as episode managers responsible for downstream risk and accountable to upstream payers. 

• Leaders need to keep the focus on readmissions, ED use, and long-term function—not just clean documentation and Lcode lists. (And getting that readmission and ED use visit information will not be easy for O&P.)

That kind of change is slow and sometimes uncomfortable, especially in lean practices where everyone is already stretched. 

3. Relationship and negotiation work with risk bearing entities

To avoid being squeezed as a “line item,” someone from your practice has to spend real time: 

• Meeting with hospital, ACO, and health plan leaders. 

• Explaining your data and defining where O&P fits in their care pathways. 

• Negotiating your role relative to inhouse PT/OT and lower cost device options. 

Again, essential work—but totally unpaid in a fee schedule world. 

The perceptions we have to overcome

On top of the structural cost, we’re pushing uphill against some powerful assumptions. 

“O&P is just fancy DME”

Medicare’s DMEPOS framework has trained payers to see us as product suppliers, not clinical specialists. Dobson–DaVanzo and Avalere argue the opposite—O&P services change total episode costs and outcomes in ways that far exceed the device price—but that story is not yet baked into most executives’ mental models. 

“Our PTs can just handle this”

In risk bearing systems, leaders naturally ask, “Why don’t we just have our PTs manage braces and prostheses?” Avalere warns that O&P patients have highly customized devices, complex trajectories, and high dependence on technology and fit; outcomes are sensitive to specialized clinical decisions. Multidisciplinary amputee and chronic disease literature consistently shows that defined roles for surgeons, PM&R, PT/OT, and prosthetists produce better outcomes than trying to collapse responsibilities into one discipline. 

“There’s no evidence your expertise matters”

It’s true we lack direct, O&P specific data linking certification status to outcomes. But we do have: 

• Strong economic and outcomes evidence that O&P care overall lowers downstream cost. 

• Broader healthcare data showing specialized training and structured programs improve results in rehab and surgical episodes. 

• Policy arguments that enforcing licensure and credentialing in O&P would reduce fraud and protect Medicare from low value care.​ 

Our job is to connect those dots in a way that makes sense to non-O&P leaders. 

Avoiding the trap: a pragmatic stance

When you put this all together, the “value-based care trap” looks like this: 

• You invest in outcomes, culture change, and relationship building. 

• You accept more accountability for long-term results. 

• But you don’t secure clear recognition, role definitions, or payment that reflect the value you’re helping create. 

A more pragmatic path is to: 

• Start measuring a small, disciplined set of outcomes for your highest volume, highest risk patient groups. 

• Use that data to tell a local cost and quality story that leaders can’t ignore. 

• Negotiate roles and expectations in any VBC conversations before you volunteer for extra reporting or “partnerships.” 

Value-based care itself isn’t the enemy. The trap is walking into someone else’s value-based world without your own data, strategy, and guardrails.